Hannah Joseph Hospital has announced that it proposes to open its Initial Public Offering on January 22, 2026. The issue aims to raise ₹42.00 crore at the upper price band through a fresh issue of 60,00,000 equity shares. The shares are proposed to be listed on the BSE SME platform.
The issue comprises 60,00,000 equity shares with a face value of ₹10 each and a price band of ₹67 to ₹70 per share.
The equity share allocation includes up to 28,46,000 equity shares for Qualified Institutional Buyers, not less than 8,58,000 equity shares for Non-Institutional Investors, not less than 19,96,000 equity shares for Individual Investors, and 3,00,000 equity shares reserved for the Market Maker.
The anchor portion of the issue will open on January 21, 2026. The issue will open on January 22, 2026 and close on January 27, 2026.
The net proceeds from the IPO will be used for funding capital expenditure for the establishment of a Radiation Oncology Centre and for general corporate purposes.
Capital Square Advisors is the Book Running Lead Manager to the issue, while Bigshare Services Private Limited is the Registrar to the issue.
Dr Mosesjoseph Arunkumar, Chairman and Managing Director of Hannah Joseph Hospital said, “Since its inception, remained committed to delivering advanced, ethical, and patient-centric healthcare services. Our evolution from a single-specialty focus to a multi-specialty tertiary care hospital reflects our continuous investments in clinical excellence, technology, and skilled medical professionals. Being a regional referral center for complex neurological, neurosurgical, cardiac, and trauma care, we have consistently strengthened our infrastructure and clinical capabilities to meet the growing healthcare needs of South Tamil Nadu.
The proposed IPO is expected to support the Company’s planned capacity and service expansion initiatives, enabling it to strengthen its clinical offerings and deliver more integrated, end-to-end care. These initiatives are aimed at enhancing patient convenience and treatment outcomes while broadening the Company’s ability to serve complex medical needs under a single platform. The expansion is also expected to drive incremental inpatient and outpatient volumes and support sustainable growth in revenues over the medium to long term.”
Sunil Kumar Manocha, Founder and Director of Capital Square Advisors, said, “Hannah Joseph Hospital operates a tertiary care facility in its core market with a focused presence across neurosciences, cardiology, trauma, and critical care. Supported by accredited operations and participation in government insurance schemes, the hospital is positioned to deploy incremental capital towards capacity enhancement and service integration initiatives.
These initiatives are expected to expand clinical offerings, improve patient throughput and case mix, and support growth in inpatient and outpatient revenues.”